The rapid advancements in embryonic development research and artificial womb technology have garnered significant attention, but it is crucial to distinguish these developments from the concept of complete ectogenesis—gestation entirely outside the human body. Researchers, particularly at the Weizmann Institute of Science, are focused on early embryo development, using bioreactors to study the stages following implantation. These technologies, such as synthetic embryo models (SEMs), offer insights into cell differentiation and organ formation, with potential applications in fertility treatments, pregnancy disorders, and regenerative medicine. However, while these advancements are impressive, the leap to full ectogenesis remains speculative. Artificial womb technology is currently aimed at supporting premature infants, not growing a fetus from conception to birth. Ethical, legal, and societal concerns around ectogenesis are profound, ranging from defining the moral status of artificially gestated embryos to the impact on reproductive rights and parental responsibilities. Before further steps toward ectogenesis are considered, a transparent, public debate involving scientists, ethicists, and the public is essential. This discussion will ensure that the development and application of these technologies align with societal values and ethical standards, prioritizing patient needs and responsible innovation.